Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome

May 2012

New Chest guidelines will create debate over which antiplatelet drug to add to aspirin after an acute coronary syndrome.

These patients usually get clopidogrel (Plavix, etc)...but now guidelines suggest Brilinta (ticagrelor) over clopidogrel.

Brilinta is more effective...with a similar bleeding risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote